77 related articles for article (PubMed ID: 8346931)
1. [Clinical results of repeated intraperitoneal administration of CDDP in patients with ovarian cancer].
Usui N; Suzuki M; Furugen Y; Fuchiwaki T; Nagasawa I; Yamamoto T; Takeuchi H; Kuwabara Y
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1327-31. PubMed ID: 8346931
[TBL] [Abstract][Full Text] [Related]
2. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
3. Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer.
Recio FO; Piver MS; Hempling RE; Driscoll DL
Gynecol Oncol; 1998 Mar; 68(3):267-73. PubMed ID: 9570979
[TBL] [Abstract][Full Text] [Related]
4. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
[TBL] [Abstract][Full Text] [Related]
5. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of ovarian cancer with a combination of low-dose consecutive CDDP and cyclophosphamide].
Shimizu Y; Umezawa S; Takeshima N; Hirai Y; Fujimoto I; Yamauchi K; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):444-50. PubMed ID: 8496634
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin-paclitaxel chemotherapy.
Polverino G; Parazzini F; Stellato G; Scarfone G; Cipriani S; Bolis G
Gynecol Oncol; 2005 Nov; 99(2):343-7. PubMed ID: 16051334
[TBL] [Abstract][Full Text] [Related]
8. [Intraperitoneal chemotherapy of metastatic ovarian cancer].
Hasegawa E; Watanabe H; Ohmura G; Hirakawa S; Momose K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1742-4. PubMed ID: 1530346
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
Umeki H; Yamaguchi Y; Tsugata M; Wakana K; Somekawa Y; Shimabukuro K; Ohara M; Terauchi T; Ichimura M; Otsuka I; Aso T
Gan To Kagaku Ryoho; 2003 Mar; 30(3):377-82. PubMed ID: 12669397
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years.
Mizutani K; Takeuchi S; Ohashi Y; Yakushiji M; Nishimura H; Takahashi T; Maruhashi T; Ueda K; Noda K; Watanabe Y; Kawana T; Terashima Y; Ochiai K; Goto S; Takaku F; Motoyoshi K
Oncol Rep; 2003; 10(1):127-31. PubMed ID: 12469157
[TBL] [Abstract][Full Text] [Related]
12. [Significance of intermittent CDDP therapy for improving long-term prognosis in patients with advanced ovarian cancer].
Umesaki N; Yamamoto A; Nakano M; Matsumoto Y; Tsuda K; Kawabata M; Sugawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1623-30. PubMed ID: 1744459
[TBL] [Abstract][Full Text] [Related]
13. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
14. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
[TBL] [Abstract][Full Text] [Related]
16. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
17. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.
Barakat RR; Almadrones L; Venkatraman ES; Aghajanian C; Brown C; Shapiro F; Curtin JP; Spriggs D
Gynecol Oncol; 1998 Apr; 69(1):17-22. PubMed ID: 9570993
[TBL] [Abstract][Full Text] [Related]
20. [Intraperitoneal cisplatin chemotherapy for ovarian cancer].
Hayashi H; Nishii H; Ueda K; Kunitou S; Wada S; Takanashi H; Kobayashi S; Yasuda M
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2043-8. PubMed ID: 11791382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
